Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04574388 · ClinicalTrials.gov registry record · NA

Evaluation of Open-Label Conditioned Placebo Analgesia for Postoperative Opioid Reduction Following Spinal Fusion

A NA study of Spine Surgery, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
51
Enrollment target
1
Study location

NCT04574388 is a NA study of Spine Surgery that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 51 participants, below the 279-participant average among 6 other Spine Surgery trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04574388, a NA study of Spine Surgery, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

This research aims to understand the impact of conditioned open label placebo (COLP) on opioid consumption and pain after surgery. The hypothesis being tested is that by pairing a non-deceptive placebo pill with regularly prescribed pain killers after surgery, will allow reduction in opioids taken while maintaining the same level of analgesia.

Conditions Studied

Interventions

  • OTHER open label placebo

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2018-11-30
Est. Completion 2020-03-10
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT04574388

The ClinicalTrials.gov registry entry for NCT04574388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 279-participant average among 6 other Spine Surgery trials with a reported enrollment target (82% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spine Surgery appearing as the primary indexed condition, and to 1 intervention - of which open label placebo is the first listed.

NCT04574388 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04574388 about?

NCT04574388 is a clinical study titled "Evaluation of Open-Label Conditioned Placebo Analgesia for Postoperative Opioid Reduction Following Spinal Fusion". This research aims to understand the impact of conditioned open label placebo (COLP) on opioid consumption and pain after surgery. The hypothesis being tested is that by pairing a non-deceptive placebo pill with regularly prescribed pain killers after surgery, will allow reduction in opioids taken w...

What is the current status of trial NCT04574388?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2018-11-30. Estimated completion is 2020-03-10.

What conditions does trial NCT04574388 study?

This clinical trial studies the following conditions: Spine Surgery.

What interventions are being tested in trial NCT04574388?

The interventions under investigation include: open label placebo (OTHER).

Who is sponsoring clinical trial NCT04574388?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04574388 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spine Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.